Skip to main content
. 2021 May 11;11:9959. doi: 10.1038/s41598-021-89419-6

Table 2.

Major adverse cardiac events in 3-month follow-up.

NCP group (n = 37) 2019 group (n = 96) χ2 p
Major adverse cardiac events, n (%) 10 (35.13) 14 (14.58) 2.796 0.094
Re-hospitalization for heart failure, n (%) 3 (8.11) 4 (4.17) 0.832 0.362
Re-hospitalization for ACS, n (%) 1 (2.7) 2 (2.08) 1.000
Death, n (%) 6 (16.22) 8 (8.33) 1.762 0.184